UNSPSC 85501622: Supplement innominate artery with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement innominate artery with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03U20KZ

UNSPSC 85501622 Supplement innominate artery with nonautologous tissue substitute, open approach is a Commodity code that shows little relevant recent state and local procurement activity. The code's name references a specific surgical procedure involving vascular reconstruction with prosthetic material, yet the six recent state and local opportunities posted under this classification are entirely unrelated to cardiovascular surgery or implantable medical devices. The posted solicitations span independent medical evaluation services for disability determinations, surgical benefit carve-out programs for health plans, occupational medical surveillance, youth detention healthcare, pharmacy benefit management, and temporary health professional staffing — none of which involve the arterial supplementation procedures the code nominally describes. This mismatch suggests either miscoding at the issuing level or a fundamental misalignment between the code's scope and how state and local procurement offices are currently applying it.

The issuing bodies using this code across the recent opportunities include a city retirement office (Phoenix), municipal health systems (Long Beach), a state transportation department (Washington), a county juvenile justice agency (Harris County), county human resources divisions (Collier County), and regional health systems (Santa Clara County). Geographic spread includes Arizona, California, Florida, Texas, and Washington, with no concentration in any single state. Because the posted opportunities bear no substantive relationship to innominate artery procedures, vascular surgery, or implantable medical devices, firms pursuing work under this code should verify the actual scope directly with issuing bodies before bid preparation; the nominal code classification does not reliably signal procurement intent in this category.